"At the Hinda and Arthur Marcus Institute for Aging Research, Harvard Medical School-affiliated researchers uncover answers to the most pressing challenges of aging. Over its more than 50 years, the Marcus Institute has discovered innovative treatments and proven best practices that help seniors live longer, more active, and more fulfilling lives. We partner with leading research organizations around the world and our research portfolio ranks us in the top 11 percent of institutions funded by the National Institutes of Health."

During the past decade, Hinda and Arthur Marcus Institute for Aging Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hinda and Arthur Marcus Institute for Aging Research" #1 collaborator was "Hebrew SeniorLife" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hinda and Arthur Marcus Institute for Aging Research" are "Alzheimer Disease" (2 trials), "Healthy" (1 trials), "Major Depressive Disorder" (1 trials) and "Memory Loss" (1 trials). Many other conditions were trialed in "Hinda and Arthur Marcus Institute for Aging Research" in a lesser frequency.

Most popular intervention types in "Hinda and Arthur Marcus Institute for Aging Research" are "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Medical Food: SBD111" (1 trials), "Placebo" (1 trials), "Transcranial alternating current stimulation (tACS)" (1 trials), "tDCS" (1 trials) and "transcranial alternating current stimulation (tACS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hinda and Arthur Marcus Institute for Aging Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hinda and Arthur Marcus Institute for Aging Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hinda and Arthur Marcus Institute for Aging Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hinda and Arthur Marcus Institute for Aging Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".